Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

New COVID model predicts over 1 million deaths in China through 2023

Published 17/12/2022, 02:31
Updated 17/12/2022, 05:57
© Reuters. A resident receives a nasal spray vaccine as a second booster dose against coronavirus disease (COVID-19), at a vaccination site in Beijing, China December 16, 2022. cnsphoto via REUTERS

By Julie Steenhuysen and Deena Beasley

CHICAGO (Reuters) - China's abrupt lifting of stringent COVID-19 restrictions could result in an explosion of cases and over a million deaths through 2023, according to new projections from the U.S.-based Institute of Health Metrics and Evaluation (IHME).

According to the group's projections, cases in China would peak around April 1, when deaths would reach 322,000. About a third of China's population will have been infected by then, IHME Director Christopher Murray said.

China's national health authority has not reported anyofficial COVID deaths since the lifting of COVID restrictions. The last official deaths were reported on Dec. 3.

Total pandemic fatalities stand at 5,235.

China lifted some of the world's toughest COVID restrictions in December after unprecedented public protests and is now experiencing a spike in infections, with fears COVID could sweep across its 1.4 billion population during next month's Lunar New Year holiday.

"Nobody thought they would stick to zero-COVID as long as they did," Murray said on Friday when the IHME projections were released online.

China's zero-COVID policy may have been effective at keeping earlier variants of the virus at bay, but the high transmissibility of Omicron variants made it impossible to sustain, he said.

The independent modeling group at the University of Washington in Seattle, which has been relied on by governments and companies throughout the pandemic, drew on provincial data and information from a recent Omicron outbreak in Hong Kong.

"China has since the original Wuhan outbreak barely reported any deaths. That is why we looked to Hong Kong to get an idea of the infection fatality rate," Murray said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

For its forecasts, IHME also uses information on vaccination rates provided by the Chinese government as well as assumptions on how various provinces will respond as infection rates increase.

Other experts expect some 60% of China's population will eventually be infected, with a peak expected in January, hitting vulnerable populations, such as the elderly and those with pre-existing conditions, the hardest.

Key concerns include China's large pool of susceptible individuals, the use of less effective vaccines and low vaccine coverage among those 80 and older, who are at greatest risk of severe disease.

OTHER MODELS

Disease modelers at the University of Hong Kong predict that lifting COVID restrictions and simultaneously reopening all provinces in December 2022 through January 2023 would result in 684 deaths per million people during that timeframe, according to a paper released on Wednesday on the Medrxiv preprint server that has yet to undergo peer review.

Based on China's population of 1.41 billion, and without measures such as a mass vaccination booster campaign, that amounts to 964,400 deaths.

Another study published July 2022 in Nature Medicine by researchers at the School of Public Health at Fudan University in Shanghai predicted an Omicron wave absent restrictions would result in 1.55 million deaths over a six month period, and peak demand for intensive care units of 15.6 times higher than existing capacity.

Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations, said there are 164 million people in China with diabetes, a risk factor for poor COVID outcomes. There are also 8 million people aged 80 and older who have never been vaccinated.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Chinese officials are now encouraging individuals to get boosted from a list of newer Chinese-made shots, however, the government is still reluctant to use foreign vaccines, Huang said.

China's National Health Commission said on Friday it wasramping up vaccinations and building stocks of ventilators andessential drugs.

(Additional reporting from Deena Beasley in Los Angeles; editing by Caroline Humer and Michael Perry)

Latest comments

Americans will save us all from the worse /sarcasm
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.